PDB Short entry for 1LF8 HEADER SIGNALING PROTEIN 10-APR-02 1LF8 TITLE COMPLEX OF GGA3-VHS DOMAIN AND CI-MPR C-TERMINAL PHOSPHOPEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA3; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: VHS DOMAIN (RESIDUES 1-166); COMPND 5 SYNONYM: GOLGI-LOCALIZED, GAMMA EAR-CONTAINING, ARF-BINDING PROTEIN COMPND 6 3; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CATION-INDEPENDENT MANNOSE-6-PHOSPHATE RECEPTOR; COMPND 10 CHAIN: E, F, G, H; COMPND 11 FRAGMENT: C-TERMINUS (RESIDUES 2480-2491); COMPND 12 SYNONYM: CI MAN-6-P RECEPTOR, CI-MPR, INSULIN-LIKE GROWTH FACTOR II COMPND 13 RECEPTOR; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PHIS-PARALLEL2; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 13 OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS (HUMAN). KEYWDS VHS DOMAIN, PROTEIN-PHOSPHOPEPTIDE COMPLEX, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.KATO,S.MISRA,R.PUERTOLLANO,J.H.HURLEY,J.S.BONIFACINO REVDAT 4 16-AUG-23 1LF8 1 SEQADV LINK REVDAT 3 24-FEB-09 1LF8 1 VERSN REVDAT 2 01-APR-03 1LF8 1 JRNL REVDAT 1 26-JUN-02 1LF8 0 JRNL AUTH Y.KATO,S.MISRA,R.PUERTOLLANO,J.H.HURLEY,J.S.BONIFACINO JRNL TITL PHOSPHOREGULATION OF SORTING SIGNAL-VHS DOMAIN INTERACTIONS JRNL TITL 2 BY A DIRECT ELECTROSTATIC MECHANISM. JRNL REF NAT.STRUCT.BIOL. V. 9 532 2002 JRNL REFN ISSN 1072-8368 JRNL PMID 12032548 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 89.83 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 713707.580 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.8 REMARK 3 NUMBER OF REFLECTIONS : 36130 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3600 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4702 REMARK 3 BIN R VALUE (WORKING SET) : 0.2640 REMARK 3 BIN FREE R VALUE : 0.3220 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 503 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.014 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5283 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 300 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.14000 REMARK 3 B22 (A**2) : 2.96000 REMARK 3 B33 (A**2) : -8.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.23 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.30 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.480 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.460 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.390 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.250 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.390 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 42.66 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : SEP2.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : SEP2.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1LF8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-APR-02. REMARK 100 THE DEPOSITION ID IS D_1000015895. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-OCT-01 REMARK 200 TEMPERATURE (KELVIN) : 95 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37720 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 20.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.35600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1JUQ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM CAPS 10.2-11.0, 200 MM LITHIUM REMARK 280 SULFATE, 1.3-2M SODIUM/POTASSIUM PHOSPHATE, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.29000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.29000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 62.27000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 64.85000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 62.27000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 64.85000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 54.29000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 62.27000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 64.85000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 54.29000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 62.27000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 64.85000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: EACH VHS DOMAIN/PHOSPHOPEPTIDE COMPLEX CORRESPONDS TO A REMARK 300 SINGLE BIOLOGICAL UNIT. THERE ARE THE EQUIVALENT OF 4 BIOLOGICAL REMARK 300 COMPLEXES PER ASYMMETRIC UNIT. THE APPARENT VHS DOMAIN DIMER IS REMARK 300 LIKELY A CRYSTALLIZATION ARTIFACT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8460 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8980 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 ALA A -3 REMARK 465 MET A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 GLU A 3 REMARK 465 ALA A 4 REMARK 465 GLU A 5 REMARK 465 GLY A 6 REMARK 465 PRO A 158 REMARK 465 SER A 159 REMARK 465 PRO A 160 REMARK 465 PRO A 161 REMARK 465 PRO A 162 REMARK 465 ARG A 163 REMARK 465 PRO A 164 REMARK 465 LYS A 165 REMARK 465 ASN A 166 REMARK 465 GLY B -4 REMARK 465 ALA B -3 REMARK 465 MET B -2 REMARK 465 PRO B 158 REMARK 465 SER B 159 REMARK 465 PRO B 160 REMARK 465 PRO B 161 REMARK 465 PRO B 162 REMARK 465 ARG B 163 REMARK 465 PRO B 164 REMARK 465 LYS B 165 REMARK 465 ASN B 166 REMARK 465 GLY C -4 REMARK 465 ALA C -3 REMARK 465 MET C -2 REMARK 465 GLY C -1 REMARK 465 SER C 0 REMARK 465 MET C 1 REMARK 465 ALA C 2 REMARK 465 GLU C 3 REMARK 465 ALA C 4 REMARK 465 GLU C 5 REMARK 465 GLY C 6 REMARK 465 GLU C 7 REMARK 465 ILE C 157 REMARK 465 PRO C 158 REMARK 465 SER C 159 REMARK 465 PRO C 160 REMARK 465 PRO C 161 REMARK 465 PRO C 162 REMARK 465 ARG C 163 REMARK 465 PRO C 164 REMARK 465 LYS C 165 REMARK 465 ASN C 166 REMARK 465 GLY D -4 REMARK 465 ALA D -3 REMARK 465 MET D -2 REMARK 465 PRO D 158 REMARK 465 SER D 159 REMARK 465 PRO D 160 REMARK 465 PRO D 161 REMARK 465 PRO D 162 REMARK 465 ARG D 163 REMARK 465 PRO D 164 REMARK 465 LYS D 165 REMARK 465 ASN D 166 REMARK 465 PHE E 301 REMARK 465 HIS E 302 REMARK 465 ASP E 303 REMARK 465 ASP E 304 REMARK 465 PHE F 301 REMARK 465 HIS F 302 REMARK 465 ASP F 303 REMARK 465 ASP F 304 REMARK 465 PHE G 301 REMARK 465 HIS G 302 REMARK 465 ASP G 303 REMARK 465 ASP G 304 REMARK 465 PHE H 301 REMARK 465 HIS H 302 REMARK 465 ASP H 303 REMARK 465 ASP H 304 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH D 217 O HOH D 251 0.00 REMARK 500 N GLU D 70 O HOH D 240 1.92 REMARK 500 O LEU D 66 O HOH D 240 2.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH D 258 O HOH D 258 3555 0.99 REMARK 500 O HOH B 176 O HOH B 176 4555 1.20 REMARK 500 O HOH D 252 O HOH D 252 3555 1.49 REMARK 500 O HOH C 232 O HOH C 232 3655 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 101 -107.46 -126.91 REMARK 500 LEU A 125 67.43 -112.94 REMARK 500 LEU A 156 28.11 -74.89 REMARK 500 TYR B 101 -87.66 -132.94 REMARK 500 LEU B 125 66.08 -118.88 REMARK 500 LEU B 156 53.65 -91.32 REMARK 500 TYR C 101 -108.04 -124.53 REMARK 500 GLU C 128 77.21 -111.33 REMARK 500 TYR D 101 -82.37 -126.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JPL RELATED DB: PDB REMARK 900 GGA3-VHS COMPLEX WITH (UNPHOSPHORYLATED) PEPTIDE FROM CI-MPR C- REMARK 900 TERMINUS REMARK 900 RELATED ID: 1JUQ RELATED DB: PDB REMARK 900 GGA3-VHS COMPLEX WITH PEPTIDE FROM CD-MPR C-TERMINUS REMARK 900 RELATED ID: 1JWG RELATED DB: PDB REMARK 900 GGA1-VHS COMPLEX WITH PEPTIDE FROM CI-MPR C-TERMINUS REMARK 900 RELATED ID: 1JWF RELATED DB: PDB REMARK 900 STRUCTURE OF NATIVE GGA1-VHS DOMAIN DBREF 1LF8 A 1 166 UNP Q9NZ52 GGA3_HUMAN 1 166 DBREF 1LF8 B 1 166 UNP Q9NZ52 GGA3_HUMAN 1 166 DBREF 1LF8 C 1 166 UNP Q9NZ52 GGA3_HUMAN 1 166 DBREF 1LF8 D 1 166 UNP Q9NZ52 GGA3_HUMAN 1 166 DBREF 1LF8 E 301 312 UNP P11717 MPRI_HUMAN 2480 2491 DBREF 1LF8 F 301 312 UNP P11717 MPRI_HUMAN 2480 2491 DBREF 1LF8 G 301 312 UNP P11717 MPRI_HUMAN 2480 2491 DBREF 1LF8 H 301 312 UNP P11717 MPRI_HUMAN 2480 2491 SEQADV 1LF8 GLY A -4 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 ALA A -3 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 MET A -2 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 GLY A -1 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 SER A 0 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 GLY B -4 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 ALA B -3 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 MET B -2 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 GLY B -1 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 SER B 0 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 GLY C -4 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 ALA C -3 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 MET C -2 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 GLY C -1 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 SER C 0 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 GLY D -4 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 ALA D -3 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 MET D -2 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 GLY D -1 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 SER D 0 UNP Q9NZ52 CLONING ARTIFACT SEQADV 1LF8 SEP E 305 UNP P11717 SER 2484 MODIFIED RESIDUE SEQADV 1LF8 SEP F 305 UNP P11717 SER 2484 MODIFIED RESIDUE SEQADV 1LF8 SEP G 305 UNP P11717 SER 2484 MODIFIED RESIDUE SEQADV 1LF8 SEP H 305 UNP P11717 SER 2484 MODIFIED RESIDUE SEQRES 1 A 171 GLY ALA MET GLY SER MET ALA GLU ALA GLU GLY GLU SER SEQRES 2 A 171 LEU GLU SER TRP LEU ASN LYS ALA THR ASN PRO SER ASN SEQRES 3 A 171 ARG GLN GLU ASP TRP GLU TYR ILE ILE GLY PHE CYS ASP SEQRES 4 A 171 GLN ILE ASN LYS GLU LEU GLU GLY PRO GLN ILE ALA VAL SEQRES 5 A 171 ARG LEU LEU ALA HIS LYS ILE GLN SER PRO GLN GLU TRP SEQRES 6 A 171 GLU ALA LEU GLN ALA LEU THR VAL LEU GLU ALA CYS MET SEQRES 7 A 171 LYS ASN CYS GLY ARG ARG PHE HIS ASN GLU VAL GLY LYS SEQRES 8 A 171 PHE ARG PHE LEU ASN GLU LEU ILE LYS VAL VAL SER PRO SEQRES 9 A 171 LYS TYR LEU GLY ASP ARG VAL SER GLU LYS VAL LYS THR SEQRES 10 A 171 LYS VAL ILE GLU LEU LEU TYR SER TRP THR MET ALA LEU SEQRES 11 A 171 PRO GLU GLU ALA LYS ILE LYS ASP ALA TYR HIS MET LEU SEQRES 12 A 171 LYS ARG GLN GLY ILE VAL GLN SER ASP PRO PRO ILE PRO SEQRES 13 A 171 VAL ASP ARG THR LEU ILE PRO SER PRO PRO PRO ARG PRO SEQRES 14 A 171 LYS ASN SEQRES 1 B 171 GLY ALA MET GLY SER MET ALA GLU ALA GLU GLY GLU SER SEQRES 2 B 171 LEU GLU SER TRP LEU ASN LYS ALA THR ASN PRO SER ASN SEQRES 3 B 171 ARG GLN GLU ASP TRP GLU TYR ILE ILE GLY PHE CYS ASP SEQRES 4 B 171 GLN ILE ASN LYS GLU LEU GLU GLY PRO GLN ILE ALA VAL SEQRES 5 B 171 ARG LEU LEU ALA HIS LYS ILE GLN SER PRO GLN GLU TRP SEQRES 6 B 171 GLU ALA LEU GLN ALA LEU THR VAL LEU GLU ALA CYS MET SEQRES 7 B 171 LYS ASN CYS GLY ARG ARG PHE HIS ASN GLU VAL GLY LYS SEQRES 8 B 171 PHE ARG PHE LEU ASN GLU LEU ILE LYS VAL VAL SER PRO SEQRES 9 B 171 LYS TYR LEU GLY ASP ARG VAL SER GLU LYS VAL LYS THR SEQRES 10 B 171 LYS VAL ILE GLU LEU LEU TYR SER TRP THR MET ALA LEU SEQRES 11 B 171 PRO GLU GLU ALA LYS ILE LYS ASP ALA TYR HIS MET LEU SEQRES 12 B 171 LYS ARG GLN GLY ILE VAL GLN SER ASP PRO PRO ILE PRO SEQRES 13 B 171 VAL ASP ARG THR LEU ILE PRO SER PRO PRO PRO ARG PRO SEQRES 14 B 171 LYS ASN SEQRES 1 C 171 GLY ALA MET GLY SER MET ALA GLU ALA GLU GLY GLU SER SEQRES 2 C 171 LEU GLU SER TRP LEU ASN LYS ALA THR ASN PRO SER ASN SEQRES 3 C 171 ARG GLN GLU ASP TRP GLU TYR ILE ILE GLY PHE CYS ASP SEQRES 4 C 171 GLN ILE ASN LYS GLU LEU GLU GLY PRO GLN ILE ALA VAL SEQRES 5 C 171 ARG LEU LEU ALA HIS LYS ILE GLN SER PRO GLN GLU TRP SEQRES 6 C 171 GLU ALA LEU GLN ALA LEU THR VAL LEU GLU ALA CYS MET SEQRES 7 C 171 LYS ASN CYS GLY ARG ARG PHE HIS ASN GLU VAL GLY LYS SEQRES 8 C 171 PHE ARG PHE LEU ASN GLU LEU ILE LYS VAL VAL SER PRO SEQRES 9 C 171 LYS TYR LEU GLY ASP ARG VAL SER GLU LYS VAL LYS THR SEQRES 10 C 171 LYS VAL ILE GLU LEU LEU TYR SER TRP THR MET ALA LEU SEQRES 11 C 171 PRO GLU GLU ALA LYS ILE LYS ASP ALA TYR HIS MET LEU SEQRES 12 C 171 LYS ARG GLN GLY ILE VAL GLN SER ASP PRO PRO ILE PRO SEQRES 13 C 171 VAL ASP ARG THR LEU ILE PRO SER PRO PRO PRO ARG PRO SEQRES 14 C 171 LYS ASN SEQRES 1 D 171 GLY ALA MET GLY SER MET ALA GLU ALA GLU GLY GLU SER SEQRES 2 D 171 LEU GLU SER TRP LEU ASN LYS ALA THR ASN PRO SER ASN SEQRES 3 D 171 ARG GLN GLU ASP TRP GLU TYR ILE ILE GLY PHE CYS ASP SEQRES 4 D 171 GLN ILE ASN LYS GLU LEU GLU GLY PRO GLN ILE ALA VAL SEQRES 5 D 171 ARG LEU LEU ALA HIS LYS ILE GLN SER PRO GLN GLU TRP SEQRES 6 D 171 GLU ALA LEU GLN ALA LEU THR VAL LEU GLU ALA CYS MET SEQRES 7 D 171 LYS ASN CYS GLY ARG ARG PHE HIS ASN GLU VAL GLY LYS SEQRES 8 D 171 PHE ARG PHE LEU ASN GLU LEU ILE LYS VAL VAL SER PRO SEQRES 9 D 171 LYS TYR LEU GLY ASP ARG VAL SER GLU LYS VAL LYS THR SEQRES 10 D 171 LYS VAL ILE GLU LEU LEU TYR SER TRP THR MET ALA LEU SEQRES 11 D 171 PRO GLU GLU ALA LYS ILE LYS ASP ALA TYR HIS MET LEU SEQRES 12 D 171 LYS ARG GLN GLY ILE VAL GLN SER ASP PRO PRO ILE PRO SEQRES 13 D 171 VAL ASP ARG THR LEU ILE PRO SER PRO PRO PRO ARG PRO SEQRES 14 D 171 LYS ASN SEQRES 1 E 12 PHE HIS ASP ASP SEP ASP GLU ASP LEU LEU HIS ILE SEQRES 1 F 12 PHE HIS ASP ASP SEP ASP GLU ASP LEU LEU HIS ILE SEQRES 1 G 12 PHE HIS ASP ASP SEP ASP GLU ASP LEU LEU HIS ILE SEQRES 1 H 12 PHE HIS ASP ASP SEP ASP GLU ASP LEU LEU HIS ILE MODRES 1LF8 SEP E 305 SER PHOSPHOSERINE MODRES 1LF8 SEP F 305 SER PHOSPHOSERINE MODRES 1LF8 SEP G 305 SER PHOSPHOSERINE MODRES 1LF8 SEP H 305 SER PHOSPHOSERINE HET SEP E 305 10 HET SEP F 305 10 HET SEP G 305 10 HET SEP H 305 20 HETNAM SEP PHOSPHOSERINE HETSYN SEP PHOSPHONOSERINE FORMUL 5 SEP 4(C3 H8 N O6 P) FORMUL 9 HOH *300(H2 O) HELIX 1 1 SER A 8 ASN A 18 1 11 HELIX 2 2 ASP A 25 GLU A 39 1 15 HELIX 3 3 GLU A 41 GLN A 55 1 15 HELIX 4 4 GLN A 58 CYS A 76 1 19 HELIX 5 5 CYS A 76 GLY A 85 1 10 HELIX 6 6 LYS A 86 SER A 98 1 13 HELIX 7 7 LEU A 102 VAL A 106 5 5 HELIX 8 8 SER A 107 LEU A 125 1 19 HELIX 9 9 GLU A 128 GLN A 141 1 14 HELIX 10 10 GLY B -1 ALA B 2 5 4 HELIX 11 11 GLU B 3 ASN B 18 1 16 HELIX 12 12 ASP B 25 GLU B 39 1 15 HELIX 13 13 GLU B 41 GLN B 55 1 15 HELIX 14 14 GLN B 58 CYS B 76 1 19 HELIX 15 15 CYS B 76 GLY B 85 1 10 HELIX 16 16 LYS B 86 SER B 98 1 13 HELIX 17 17 LEU B 102 VAL B 106 5 5 HELIX 18 18 SER B 107 LEU B 125 1 19 HELIX 19 19 GLU B 128 GLN B 141 1 14 HELIX 20 20 SER C 8 THR C 17 1 10 HELIX 21 21 ASP C 25 GLU C 39 1 15 HELIX 22 22 GLU C 41 GLN C 55 1 15 HELIX 23 23 GLN C 58 CYS C 76 1 19 HELIX 24 24 CYS C 76 GLY C 85 1 10 HELIX 25 25 LYS C 86 SER C 98 1 13 HELIX 26 26 LEU C 102 VAL C 106 5 5 HELIX 27 27 SER C 107 LEU C 125 1 19 HELIX 28 28 GLU C 128 GLN C 141 1 14 HELIX 29 29 GLY D -1 ALA D 2 5 4 HELIX 30 30 GLU D 3 THR D 17 1 15 HELIX 31 31 ASP D 25 GLU D 39 1 15 HELIX 32 32 GLU D 41 GLN D 55 1 15 HELIX 33 33 GLN D 58 CYS D 76 1 19 HELIX 34 34 CYS D 76 GLY D 85 1 10 HELIX 35 35 LYS D 86 SER D 98 1 13 HELIX 36 36 SER D 107 LEU D 125 1 19 HELIX 37 37 GLU D 128 GLN D 141 1 14 LINK C SEP E 305 N ASP E 306 1555 1555 1.33 LINK C SEP F 305 N ASP F 306 1555 1555 1.33 LINK C SEP G 305 N ASP G 306 1555 1555 1.33 LINK C BSEP H 305 N ASP H 306 1555 1555 1.33 LINK C ASEP H 305 N ASP H 306 1555 1555 1.32 CRYST1 124.540 129.700 108.580 90.00 90.00 90.00 C 2 2 21 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008030 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007710 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009210 0.00000